Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2

Conditions

Lymphoma, T-Cell, Cutaneous 30Precursor Cell Lymphoblastic Leukemia-Lymphoma 28Lymphoma, Follicular 28Lymphoma, B-Cell, Marginal Zone 28Leukemia, Lymphocytic, Chronic, B-Cell 28Lymphoma, Non-Hodgkin 27Lymphoma, Mantle-Cell 26Lymphoma, Large B-Cell, Diffuse 26Sezary Syndrome 25Mycosis Fungoides 25Leukemia, Myeloid, Acute 25Hodgkin Disease 25Multiple Myeloma 24Lymphoma, Large-Cell, Immunoblastic 24Congenital Abnormalities 24Burkitt Lymphoma 24Leukemia, Myeloid, Chronic-Phase 20Leukemia, Myeloid, Accelerated Phase 20Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 19Lymphoma, Extranodal NK-T-Cell 19Myeloproliferative Disorders 18Lymphoma, Large-Cell, Anaplastic 18Waldenstrom Macroglobulinemia 17Recurrence 16Leukemia, Myelomonocytic, Chronic 16Immunoblastic Lymphadenopathy 16Dendritic Cell Sarcoma, Interdigitating 16Lymphoma 15Leukemia, Hairy Cell 15Leukemia 15

Interventions

pembrolizumab 300Nivolumab 273Ipilimumab 250aldesleukin 137Cyclophosphamide 136Interleukin-2 105trametinib 82dabrafenib 76Temozolomide 75Dacarbazine 74Vemurafenib 71fludarabine 68fludarabine phosphate 62Biopsy 49binimetinib 47sargramostim 44Radiosurgery 44Bevacizumab 43Paclitaxel 42encorafenib 40incomplete Freund's adjuvant 39atezolizumab 38Radiotherapy 37Specimen Handling 36Cisplatin 36CTLA-4 Antigen 36Magnetic Resonance Spectroscopy 35Carboplatin 35cobimetinib 34Introns 33

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Melanoma × Mycophenolic Acid × Dermatologic × Clear all
NCT07619898 2026-06-02

PHOENIX-ECP

Therakos LLC

Phase 2 Not yet recruiting
112 enrolled
Dermatologic

Colitis, Hepatitis, Melanoma

NCT00006233 2011-11-30

Combination Chemotherapy, Total-Body Irradiation, Peripheral Stem Cell Transplantation, and Lymphocyte Infusion in Treating Patients With Stage IV Melanoma

Fred Hutchinson Cancer Center

Phase 2 Completed
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡